ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

ASCO Honors Eight With Special Awards

May 24, 2002

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

NIH Releases Digestive Diseases Research Plan

May 1, 2009